A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

Philadelphia has lagged in biotech R&D jobs despite University of Pennsylvania scientists playing a leading role in ...

For the third year in a row, Fierce Biotech’s Layoff Tracker is topping the tree as the story with the highest number of ...

The new saw: Development-stage biotechs are maturing. Their drugs are winning approvals and independent commercial launches ...

Is the biotech industry truly out of its slump? This week on "The Readout LOUD," a biotech year in review and a look ahead to ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several portfolio moves across biotech and growth stocks on ...

Aktis Oncology filed for an initial public offering in the United States on Friday, as stock market listings from the biotech ...